210 related articles for article (PubMed ID: 16935796)
41. In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.
Med Lett Drugs Ther; 2015 Apr; 57(1467):e66. PubMed ID: 25988964
[No Abstract] [Full Text] [Related]
42. Unilesional mycosis fungoides successfully treated with imiquimod.
Ardigò M; Cota C; Berardesca E
Eur J Dermatol; 2006; 16(4):446. PubMed ID: 16935811
[No Abstract] [Full Text] [Related]
43. [Topical application of ACNU for the treatment of mycosis fungoides].
Jimbow K; Horikoshi T; Kamimura M
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1231-6. PubMed ID: 6964047
[TBL] [Abstract][Full Text] [Related]
44. Topical treatment of early cutaneous T-cell lymphoma.
Ramsay DL; Meller JA; Zackheim HS
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
[TBL] [Abstract][Full Text] [Related]
45. [Cutaneous T-cell lymphoma bullosa: 2 cases].
Héliot I; Beylot-Barry M; Vergier B; Doutre MS; Beylot C
Ann Dermatol Venereol; 2003; 130(6-7):639-42. PubMed ID: 13679703
[TBL] [Abstract][Full Text] [Related]
46. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
47. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
48. Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.
Kheterpal M; Mehta-Shah N; Virmani P; Myskowski PL; Moskowitz A; Horwitz SM
Curr Hematol Malig Rep; 2016 Jun; 11(3):224-33. PubMed ID: 27101016
[TBL] [Abstract][Full Text] [Related]
49. Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure.
Del Guzzo CA; Kojadinovic A; Vinnakota RR; Geskin LJ; Newman JC; Langhoff E; Park YA; Bates SE; Dana AN
Oncologist; 2021 Sep; 26(9):727-e1488. PubMed ID: 33851477
[TBL] [Abstract][Full Text] [Related]
50. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
51. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
52. Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol.
French LE; Saurat JH
Lancet; 1995 Aug; 346(8971):376. PubMed ID: 7623546
[No Abstract] [Full Text] [Related]
53. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
54. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
55. Skin-Directed Therapies in Cutaneous T-Cell Lymphoma.
Nguyen CV; Bohjanen KA
Dermatol Clin; 2015 Oct; 33(4):683-96. PubMed ID: 26433841
[TBL] [Abstract][Full Text] [Related]
56. Pyoderma gangrenosum-like CD30+ cutaneous T-cell lymphoma in a patient with mycosis fungoides.
Cozzani E; Scaparro M; Rongioletti F; Pierri I; Pimpinelli N; Parodi A
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):819-21. PubMed ID: 24576263
[No Abstract] [Full Text] [Related]
57. Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa.
Jumbou O; N'Guyen JM; Tessier MH; Legoux B; Dréno B
Br J Dermatol; 1999 Mar; 140(3):427-31. PubMed ID: 10233261
[TBL] [Abstract][Full Text] [Related]
58. Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma.
Nouri K; O'Connell C; Rivas MP
J Drugs Dermatol; 2003 Dec; 2(6):669-73. PubMed ID: 14711149
[TBL] [Abstract][Full Text] [Related]
59. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma.
Zane C; Venturini M; Sala R; Calzavara-Pinton P
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):254-8. PubMed ID: 16948827
[TBL] [Abstract][Full Text] [Related]
60. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
